Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
Clinical trial NCT04804111 · COMPLETED
Trial details
- NCT number
- NCT04804111
- Sponsor
- JW Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-21
- Primary completion
- 2020-09-04
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.